Asset Allocation

As of November 30, 2025.
Type % Net
Cash 5.90%
Stock 80.32%
Bond 8.69%
Convertible 0.00%
Preferred 0.00%
Other 5.09%
View Asset Allocation
Start Trial

Market Capitalization

As of November 30, 2025
Large 81.83%
Mid 14.73%
Small 3.44%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 88.43%    % Emerging Markets: 0.00%    % Unidentified Markets: 11.57%

Americas 86.10%
85.96%
Canada 0.04%
United States 85.92%
0.15%
As of November 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 2.05%
United Kingdom 0.43%
1.45%
France 0.03%
Germany 0.00%
Ireland 1.10%
Netherlands 0.07%
Switzerland 0.25%
0.00%
0.17%
Israel 0.17%
Greater Asia 0.28%
Japan 0.17%
0.02%
Australia 0.02%
0.09%
Singapore 0.08%
South Korea 0.01%
0.00%
Unidentified Region 11.57%

Bond Credit Quality Exposure

AAA 10.15%
AA 2.36%
A 3.12%
BBB 5.48%
BB 1.33%
B 0.37%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 1.84%
Not Available 75.35%
Short Term 0.00%
As of November 30, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
24.41%
Materials
1.52%
Consumer Discretionary
9.42%
Financials
11.82%
Real Estate
1.65%
Sensitive
50.84%
Communication Services
9.69%
Energy
2.57%
Industrials
7.03%
Information Technology
31.55%
Defensive
15.25%
Consumer Staples
4.26%
Health Care
8.84%
Utilities
2.15%
Not Classified
9.50%
Non Classified Equity
0.05%
Not Classified - Non Equity
9.46%
As of November 30, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of November 30, 2025
Type % Net
Government 68.02%
Corporate 7.60%
Securitized 23.51%
Municipal 0.00%
Other 0.87%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
69.58%
Less than 1 Year
69.58%
Intermediate
9.23%
1 to 3 Years
4.13%
3 to 5 Years
3.10%
5 to 10 Years
2.00%
Long Term
20.82%
10 to 20 Years
7.56%
20 to 30 Years
7.97%
Over 30 Years
5.29%
Other
0.37%
As of November 30, 2025
View Bond Maturity Exposure
Start Trial